CADL
Price
$6.67
Change
-$1.03 (-13.39%)
Updated
Jan 17 closing price
Capitalization
296.43M
68 days until earnings call
NKTR
Price
$0.89
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
164.54M
40 days until earnings call
Ad is loading...

CADL vs NKTR

Header iconCADL vs NKTR Comparison
Open Charts CADL vs NKTRBanner chart's image
Candel Therapeutics
Price$6.67
Change-$1.03 (-13.39%)
Volume$1.91M
Capitalization296.43M
Nektar Therapeutics
Price$0.89
Change-$0.00 (-0.00%)
Volume$1.79M
Capitalization164.54M
CADL vs NKTR Comparison Chart
Loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CADL vs. NKTR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and NKTR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CADL: $6.66 vs. NKTR: $0.89)
Brand notoriety: CADL: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 37% vs. NKTR: 94%
Market capitalization -- CADL: $296.43M vs. NKTR: $164.54M
CADL [@Biotechnology] is valued at $296.43M. NKTR’s [@Biotechnology] market capitalization is $164.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, CADL is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while NKTR’s TA Score has 4 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 3 bearish.
  • NKTR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CADL is a better buy in the short-term than NKTR.

Price Growth

CADL (@Biotechnology) experienced а -18.52% price change this week, while NKTR (@Biotechnology) price change was -13.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CADL is expected to report earnings on Mar 27, 2025.

NKTR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($296M) has a higher market cap than NKTR($165M). NKTR YTD gains are higher at: -4.086 vs. CADL (-23.214). CADL has higher annual earnings (EBITDA): -48.83M vs. NKTR (-137.77M). NKTR has more cash in the bank: 244M vs. CADL (16.6M). CADL has less debt than NKTR: CADL (16M) vs NKTR (108M). NKTR has higher revenues than CADL: NKTR (93.1M) vs CADL (0).
CADLNKTRCADL / NKTR
Capitalization296M165M179%
EBITDA-48.83M-137.77M35%
Gain YTD-23.214-4.086568%
P/E RatioN/AN/A-
Revenue093.1M-
Total Cash16.6M244M7%
Total Debt16M108M15%
FUNDAMENTALS RATINGS
NKTR: Fundamental Ratings
NKTR
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CADLNKTR
RSI
ODDS (%)
N/A
Bearish Trend 11 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
86%
Bullish Trend 11 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
74%
Advances
ODDS (%)
Bullish Trend 16 days ago
86%
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Aroon
ODDS (%)
Bullish Trend 11 days ago
84%
Bearish Trend 11 days ago
86%
View a ticker or compare two or three
Ad is loading...
CADL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
INSCX19.100.50
+2.69%
Catalyst Insider Buying C
BUIDX33.270.21
+0.64%
Buffalo Growth & Income Inst
JEPIX14.540.04
+0.28%
JPMorgan Equity Premium Income I
RCEYX58.08N/A
N/A
Victory RS Large Cap Alpha Y
FBTAX26.09-0.13
-0.50%
Fidelity Advisor Biotechnology A

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-13.33%
CYYNF - CADL
46%
Loosely correlated
N/A
INKT - CADL
34%
Loosely correlated
+5.77%
MDGL - CADL
33%
Poorly correlated
+7.64%
KRRO - CADL
31%
Poorly correlated
+0.05%
NKTR - CADL
29%
Poorly correlated
+0.03%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with NTLA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+0.03%
NTLA - NKTR
42%
Loosely correlated
+0.85%
SLS - NKTR
42%
Loosely correlated
+7.86%
DNLI - NKTR
41%
Loosely correlated
+1.20%
MDGL - NKTR
38%
Loosely correlated
+7.64%
IPSC - NKTR
37%
Loosely correlated
+0.45%
More